Opinion/decision on a Paediatric investigation plan (PIP): Betmiga, Mirabegron, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Uro-nephrology, PIP number: P/0550/2022

Submitted by Anonymous (not verified) on 14 February 2024 - 16:13

Opinion/decision on a Paediatric investigation plan (PIP): Betmiga, Mirabegron, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Uro-nephrology, PIP number: P/0550/2022

Opinion/decision on a Paediatric investigation plan (PIP): Opsumit, Macitentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0012/2023

Submitted by Anonymous (not verified) on 14 February 2024 - 16:06

Opinion/decision on a Paediatric investigation plan (PIP): Opsumit, Macitentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0012/2023

Opinion/decision on a Paediatric investigation plan (PIP): Doptelet, avatrombopag maleate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology, PIP number: P/0010/2023

Submitted by Anonymous (not verified) on 14 February 2024 - 15:57

Opinion/decision on a Paediatric investigation plan (PIP): Doptelet, avatrombopag maleate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology, PIP number: P/0010/2023

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness